2003-03-01
Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group
Publication
Publication
Annals of Oncology , Volume 14 - Issue 3 p. 441- 448
Additional Metadata | |
---|---|
, , , , , | |
doi.org/10.1093/annonc/mdg112, hdl.handle.net/1765/66299 | |
Annals of Oncology | |
Organisation | Department of Gynaecology & Obstetrics |
Aapro, M., van Wijk, F., Bolis, G., Chevallier, P., van der Burg, M., Poveda, A., … Vermorken, J. (2003). Doxurubicin versus doxorubicin and cisplatin in endometrial carcinoma: Definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. Annals of Oncology, 14(3), 441–448. doi:10.1093/annonc/mdg112 |